Skip to main content

Doliver Advisors, LP

SEC CIK
0000938077
Latest filing
Jul 9, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Doliver Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
9,389
Value
$852.0K
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by Doliver Advisors, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20269,389$852.0K0.2%−6,789−42.0%ReducedHolders
Q1 202616,178$1.66M0.4%−558−3.3%ReducedHolders
Q4 202516,736$2.10M0.5%+1,309+8.5%AddedHolders
Q3 202515,427$2.07M0.5%+84+0.5%AddedHolders
Q2 202515,343$2.09M0.6%+1,917+14.3%AddedHolders
Q1 202513,426$1.78M0.5%−542−3.9%ReducedHolders
Q4 202413,968$1.58M0.4%+437+3.2%AddedHolders
Q3 202413,531$1.54M0.4%+378+2.9%AddedHolders
Q2 202413,153$1.37M0.4%+1,101+9.1%AddedHolders
Q1 202412,052$1.37M0.4%−577−4.6%ReducedHolders
Q4 202312,629$1.39M0.4%+45+0.4%AddedHolders
Q3 202312,584$1.22M0.4%−187−1.5%ReducedHolders
Q2 202312,771$1.39M0.4%+168+1.3%AddedHolders
Q1 202312,603$1.28M0.4%−913−6.8%ReducedHolders
Q4 202213,516$1.48M0.5%−60.0%ReducedHolders
Q3 202213,522$1.31M0.5%+8,233+155.7%AddedHolders
Q2 20225,289$575.0K0.2%+595+12.7%AddedHolders
Q1 20224,694$556.0K0.2%+200+4.5%AddedHolders
Q4 20214,494$583.0K0.2%−2,816−38.5%ReducedHolders
Q3 20217,310$864.0K0.3%−2,590−26.2%ReducedHolders
Q2 20219,900$1.15M0.4%−11,924−54.6%ReducedHolders
Q1 202121,824$2.62M1.0%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.